Gabelli Funds’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62K Hold
15,000
– – ﹤0.01% 1230
2026
Q1
$55.5K Sell
15,000
-11,500
-43% -$48.3K ﹤0.01% 1207
2025
Q4
$91.4K Sell
26,500
-8,500
-24% -$33.9K ﹤0.01% 1185
2025
Q3
$179K Hold
35,000
– – ﹤0.01% 1161
2025
Q2
$185K Buy
+35,000
New +$255K ﹤0.01% 1144

Other funds holding RCEL

Gabelli Funds's RCEL Position: Q2 2026 in Review

Gabelli Funds held its Avita Medical (RCEL) position steady in Q2 2026 at 15,000 shares worth $62K. The position accounts for ﹤0.01% of the portfolio, ranked #1230.

Gabelli Funds first reported a position in RCEL in Q2 2025 and has held it in 5 quarters since. The position peaked at $185K in Q2 2025. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Gabelli Funds held 15,000 shares of Avita Medical worth $62K as of Q2 2026.
  • Gabelli Funds left its Avita Medical share count unchanged in Q2 2026.
  • Avita Medical made up ﹤0.01% of Gabelli Funds's portfolio in Q2 2026, its #1230 holding.
  • Gabelli Funds first reported a position in Avita Medical in Q2 2025 and has held it in 5 quarters since.
  • Gabelli Funds's Avita Medical position peaked at $185K in Q2 2025.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.